TrialPloS one2023

Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial.

Arvind Chopra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.